CIK 0001819133
- Non-accelerated filer
- Smaller reporting company
Tango Therapeutics, Inc.
Sign in to watch- Ticker
- TNGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-320-4900
- Business address
- 201 BROOKLINE AVENUE, SUITE 901, BOSTON, MA, 02215
- Former names
- BCTG Acquisition Corp.
- 4 Derivatives Options or other derivatives
- 4 Open-market sale 10% owner sold 175,000 shares at $11.60 ($2,029,703)
- 4 Open-market sale 10% owner sold 25,000 shares at $11.55 ($288,665)
- 4 Open-market sale 10% owner sold 285,000 shares at an average $9.95 ($2,835,368)
- 4 Open-market sale 10% owner sold 235,000 shares at an average $9.86 ($2,316,494)
- 4 Open-market sale 10% owner sold 50,000 shares at $9.84 ($491,950)
- 4 Open-market sale 10% owner sold 300,599 shares at an average $9.83 ($2,955,931)
- 4 Open-market sale 10% owner sold 387,740 shares at an average $9.78 ($3,793,446)
- 4 Open-market sale 10% owner sold 191,490 shares at $9.81 ($1,878,479)
- 4 Open-market sale 10% owner sold 550,171 shares at $9.79 ($5,386,339)
- 4 Open-market sale MVA Investors, LLC sold 234,731 shares at an average $8.76 ($2,055,314)
- 4 Open-market sale MVA Investors, LLC sold 140,000 shares at an average $7.04 ($985,880)
- 4 Grant or award Director acquired 6,250 shares (grant or award)
- 4 Grant or award Director acquired 6,250 shares (grant or award)
- 4 Planned sale Director sold 5,000 shares at $7.21 ($36,039)
- 4 Grant or award Director acquired 4,687 shares (grant or award)
- 4 Grant or award Director acquired 6,250 shares (grant or award)
- 4 Open-market sale MVA Investors, LLC sold 210,000 shares at an average $7.53 ($1,580,850)
- 4 Open-market sale 10% owner sold 162,500 shares at $12.00 ($1,950,000)
- 4 Open-market sale Chief Executive Officer sold 9,138 shares at an average $12.59 ($115,052)
Page 4 of 8 · 156 filings